Bindar for Islamic Finance Company (ASE:BIND)

Verve Therapeutics Revenue

Bindar for Islamic Finance Company had revenue of 3.17M JOD in the quarter ending June 30, 2025, a decrease of -4.39%. This brings the company's revenue in the last twelve months to 12.12M, up 5.00% year-over-year. In the year 2024, Bindar for Islamic Finance Company had annual revenue of 11.91M with 17.78% growth.

• Revenue (ttm): 12.12M
• Revenue Growth: +5.00%
• P/S Ratio: 3.01
• Revenue / Employee: 151.56K
• Employees: 80
• Market Cap: 36.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.91M	1.80M	17.78%
Dec 31, 2023	10.11M	1.85M	22.44%
Dec 31, 2022	8.26M	2.52M	43.98%
Dec 31, 2021	5.74M	1.01M	21.35%
Dec 31, 2020	4.73M	108.08K	2.34%